1 / 3

Central Pontine Myelinolysis Market Share, Growth, Trends, Dynamics and Industry Share By 2023

Central Pontine Myelinolysis Market Share, Growth, Trends, Dynamics and Industry Share By 2023

sandipkumar38491
Download Presentation

Central Pontine Myelinolysis Market Share, Growth, Trends, Dynamics and Industry Share By 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Central Pontine Myelinolysis Market Share, Growth, Trends, Dynamics and Industry Share By 2023 Central Pontine Myelinolysis Market Segmentation The global central pontine myelinolysis market has been segmented on the basis of diagnosis, treatment, and end users. Based on diagnosis, the market has been segmented as Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), electroencephalography and others. Based on treatment, the market has been segmented as vitamin supplementation, electrolyte maintenance and others. Based on the end users, the central pontine myelinolysis market has been segmented as hospitals & clinics, academic and research and others. Central Pontine Myelinolysis Market Regional Analysis Europe is the second largest central pontine myelinolysis market in the world due to high income and healthcare penetration. Europe is led by nations such as Germany and France. UK is expected to be the fastest growing market. Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period. The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new drugs in the US drives the central pontine myelinolysis market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The large expenditure on the US healthcare accounting to 16% of GDP also cruises the sale of central pontine myelinolysis treatment. Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/4580 Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. Central Pontine Myelinolysis Market Highlights:

  2. Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of nerve cells. The drivers for central pontine myelinolysis market are increasing risk factors and cases of liver disease, liver transplant, alcoholism, severe burns, malnutrition, anorexia, severe electrolyte disorders, AIDS, hyperemesis gravidarum, anorexia nervosa, hematopoietic stem cell transplantation, Wernicke encephalopathy etc. CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms. These neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures etc. Serious progressive neurological symptoms are, progressive development of spastic tetraparesis, pseudobulbar palsy etc. The diagnosis segment of central pontine myelinolysis especially the Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) is growing fast. MRI is the test of choice with its high specificity and correct diagnosis capabilities. The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc. Global Central pontine myelinolysisFujifilm Holdings Corporation, GE Healthcare, Siemens Healthcare GmbH, Philips Healthcare (Koninklijke Philips N.V.), Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Hitachi Medical Corporation and others. Brows More Healthcare Related Research Reports UTI Treatment Market Size, Growth Analysis | Application, 2023 Impact of COVID-19 Outbreak on Healthcare Market Asthma and COPD Drugs Market Segment, Size, Share, Global Trends, 2025 | MRFR About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country

  3. level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312 Email: sales@marketresearchfuture.com

More Related